GLUC (Glucose Health) ROE %: -89.89% (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GLUC Glucose Health Inc GLUC
38 GF Score
Price $0.39
View Full Analysis

What is Glucose Health ROE %?

Glucose Health GLUC 38 ROE % is -89.89% as of Sep. 2023. GuruFocus rates GLUC with a GF Score™ of 38/100.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Glucose Health's annualized net income for the quarter that ended in Sep. 2023 was $-0.24 Mil. Glucose Health's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $0.50 Mil. Therefore, Glucose Health's annualized ROE % for the quarter that ended in Sep. 2023 was -48.15%.

The historical rank and industry rank for Glucose Health's ROE % or its related term are showing as below:

GLUC's ROE % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 7.005
* Ranked among companies with meaningful ROE % only.

Glucose Health  (OTCPK:GLUC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-0.24245600000074/0.503554
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.24245600000074 / 0.4592480000014)*(0.4592480000014 / 0.5292905)*(0.5292905 / 0.503554)
=Net Margin %*Asset Turnover*Equity Multiplier
=-52.79 %*0.8677*1.0511
=ROA %*Equity Multiplier
=-45.81 %*1.0511
=-48.15 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-0.24245600000074/0.503554
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.24245600000074 / -0.24245600000074) * (-0.24245600000074 / -0.24245600000074) * (-0.24245600000074 / 0.4592480000014) * (0.4592480000014 / 0.5292905) * (0.5292905 / 0.503554)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1 * -52.79 % * 0.8677 * 1.0511
=-48.15 %

Note: The net income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Glucose Health ROE % Related Terms


Glucose Health ROE % Historical Data

* Premium members only.

The historical data trend for Glucose Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glucose Health ROE % Chart

Glucose Health Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Glucose Health Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Mar18 Jun18 Sep22 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity 0.00 Negative Equity -67.05 -89.89

GLUC vs RTON, BDPT, SMFL: ROE % Comparison

For the Packaged Foods subindustry, Glucose Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glucose Health ROE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Glucose Health's ROE % distribution charts can be found below:

* The bar in red indicates where Glucose Health's ROE % falls into.


GLUC
38GF Score
Glucose Health Inc GLUC
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glucose Health ROE % Calculation

Glucose Health's annualized ROE % for the fiscal year that ended in Dec. 2016 is calculated as

ROE %=Net Income (A: Dec. 2016 )/( (Total Stockholders Equity (A: Dec. 2015 )+Total Stockholders Equity (A: Dec. 2016 ))/ count )
=-0.41044300000149/( (-0.387819+-0.495447)/ 2 )
=-0.41044300000149/-0.441633
=N/A %

Glucose Health's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Sep. 2022 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-0.24245600000074/( (0.777392+0.229716)/ 2 )
=-0.24245600000074/0.503554
=-48.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -89.89% mean?
Glucose Health (GLUC) has a ROE % of -89.89% as of Sep. 2023. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Glucose Health and its competitors.
Is Glucose Health's ROE % too high?
Glucose Health's current ROE % is -89.89%. Overall, Glucose Health has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Glucose Health's ROE % compare to RTON and BDPT?
Glucose Health's ROE % of -89.89% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROE % is 7.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 7.01, based on 1,938 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Glucose Health and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glucose Health's current ROE % is -89.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glucose Health stock overvalued right now?
Glucose Health (GLUC) has a current ROE % of -89.89%. The current ROE % is -89.89%. Glucose Health's overall GF Score™ is 38/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Glucose Health (GLUC), the current ROE % is -89.89% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Glucose Health Business Description

Address 609 SW 8th Street, Suite 600, 6th Floor, Bentonville, AR, USA, 72712
Glucose Health Inc is an own-label distributor of nutritional beverages. Its niche is the formulation, manufacturing, marketing, and distribution of soluble fiber-infused nutritional beverages. The Company has identified two underserved consumer markets and has launched two brands to serve these markets, which are GlucoDown and FIBER UP. The Company currently has one single operating and reporting segment, which is the manufacturing and distribution of nutritional beverages. It generates all of its revenue from sales of nutritional beverages. The beverages are sold through the Company's website as well as through retailers.
38GF Score

Get the complete analysis for GLUC

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price